Home - Boston Life Sciences Times

City Therapeutics Reports Preclinical Data for Stargardt Disease RNAi Therapy

May 6, 2026

Sail Biomedicines Names Gene Marcantonio Chief Medical Officer

May 5, 2026

Quiver Bioscience Receives NIH Grant to Advance Non-Opioid Chronic Pain Therapy

May 4, 2026

THIS WEEK'S STORIES

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

May 1, 2026

Holyoke Medical Center Partners With IKS Health to Improve Efficiency and Support Growth

May 5, 2026

Insulet Enrolls First Participant in Pivotal Study for Fully Closed-Loop Insulin System

May 4, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Most Popular

Corbus Pharmaceuticals Renews Norwood Lease as It Advances Cancer and Obesity Pipeline

LTZ Therapeutics Raises $38 Million to Advance Immunotherapy Pipeline

Turbett Surgical Names Kevin Danahy President and CEO

Vertex Reaches German Reimbursement Agreement for CASGEVY

Recent Comments

EDITOR PICKS

City Therapeutics Reports Preclinical Data for Stargardt Disease RNAi Therapy

Sail Biomedicines Names Gene Marcantonio Chief Medical Officer

Quiver Bioscience Receives NIH Grant to Advance Non-Opioid Chronic Pain Therapy

THIS WEEK'S STORIES

Seaport Therapeutics Prices Upsized IPO at $18 Per Share

Holyoke Medical Center Partners With IKS Health to Improve Efficiency and Support Growth

Insulet Enrolls First Participant in Pivotal Study for Fully Closed-Loop Insulin System

POPULAR CATEGORY

ABOUT US

FOLLOW US

LATEST ARTICLES

Most Popular

Recent Comments

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

FOLLOW US